No profile data available.
Tempus AI, Inc. (TEM) is a healthcare company in the DNA testing equipment industry, based in Chicago, United States, with about 3,800 full-time employees.
It reported revenue of $1.27 billion for fiscal year 2025, up 83.4% from fiscal year 2024, and net income of -$245.03 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $382.49 million, up 21.6% from a year before. Its market capitalization was $12.80 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Tempus AI, Inc. operates as a healthcare technology company in the United States.
Tempus AI reported $1.27 billion in revenue for fiscal year 2025, up 83.4% from $693.40 million in fiscal year 2024. In Q2 2026 revenue was $382.49 million.
$12.80 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Natera, Inc. (NTRA), Guardant Health, Inc. (GH), Qiagen N.v. (QGEN), Caris Life Sciences, Inc. (CAI).